Stewart Craig
Corporate Officer/Principal at International Society for Cellular Therapy
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Thomas | M | 54 | 6 years | |
| H. Parker | F | 68 | 10 years | |
| Kurt C. Gunter | M | 69 |
International Society for Cellular Therapy
 International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Gernalia Satianegara | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Leslie Meltzer | M | - | 6 years | |
| Kilian Kelly | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Bobby Gaspar | M | 60 | 6 years | |
| Karen M. Nichols | F | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | 17 years |
| Burton Feinerman | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| John David Sinden | M | 73 |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Merri Buff Mair | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Richard E. Kruger | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Paul Kosnik | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Yann Godfrin | M | 52 |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Gregory Bonfiglio | M | 72 |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Uriel Barkai | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
| Anish Majumdar | M | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Rothera | M | 61 | 2 years | |
| Rodney Young | M | 61 |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 8 years |
| Robert L. Kirkman | M | 75 |
Xcyte Therapies, Inc.
| 2 years |
| Michael Steward | M | - |
Newcastle University
| 6 years |
| Choon Beng Ng | M | 58 |
Newcastle University
| 5 years |
| Charles Rowland | M | 65 | 6 years | |
| Didier Hoch | M | 68 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | - |
| Leslie Mesones | F | - | - | |
| Roger Perlmutter | M | 71 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 13 years |
| Joanne Beck | M | 63 | 6 years | |
| Jon Ellis | M | 57 | 3 years | |
| Alicia Secor | F | 62 | 6 years | |
| Nicolas Koebel | M | - | - | |
| Simone Song | F | 59 | - | |
| Marc Dunoyer | M | 71 | 6 years | |
| Michael Bodouroglou | M | 69 |
Newcastle University
| 5 years |
| Alexander Pasteur | M | 54 | - | |
| James Geraghty | M | 69 | 6 years | |
| Heather Erickson | F | - | 8 years | |
| Gregory Schiffman | M | 67 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 2 years |
| Joanna Lin Black | F | - |
Xcyte Therapies, Inc.
| 3 years |
| Elise T. Wang | F | 64 | - | |
| Christopher Henney | M | 83 |
Xcyte Therapies, Inc.
| - |
| R. Greer | M | 65 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 6 years |
| David Barrett | M | - |
Newcastle University
| 6 years |
| Moya M. Daniels | F | 55 | 2 years | |
| Neil Andrew Herrick | M | 60 |
Newcastle University
| 4 years |
| Sai Yee Wong | M | 62 |
Newcastle University
| 4 years |
| Yick Cheong Lo | M | 68 |
Newcastle University
| 4 years |
| David Gearing | M | 62 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | 1 years |
| William Armstrong | M | - |
Newcastle University
| 4 years |
| Boon Keng Teo | M | 70 |
Newcastle University
| 4 years |
| Robert Buckler | M | 58 |
Minaris Regenerative Medicine LLC
 Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ. | 2 years |
| Kaye Spratt | M | - | 18 years | |
| Robert Goodwill | M | 67 |
Newcastle University
| 4 years |
| Alistair McAdam | M | - |
Newcastle University
| 4 years |
| Yat-Ming Lam | M | 64 |
Newcastle University
| 4 years |
| Adrien Lemoine | M | - | 5 years | |
| Anthony Paul | M | - |
Newcastle University
| 4 years |
| Ling Ming Chan | M | 65 |
Newcastle University
| 4 years |
| Jason Meyenburg | M | 47 | 1 years | |
| Chin Chuan Wong | M | 66 |
Newcastle University
| 4 years |
| Wai Sheun Choy | F | 60 |
Newcastle University
| 4 years |
| Chun Kit Chu | M | 59 |
Newcastle University
| 4 years |
| Brigit Riley | M | 46 | 5 years | |
| Charles Monahan | M | - |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | 4 years |
| Rob Powell | M | - |
Newcastle University
| 3 years |
| Ioannis Panagiotis Lioupis | M | 65 |
Newcastle University
| 4 years |
| André L. Lamotte | M | 75 | - | |
| Roni Anak Adrian | M | 66 |
Newcastle University
| 4 years |
| Jeffrey Lindsay | M | - |
Newcastle University
| 4 years |
| Philip Gregory | M | 53 | 15 years | |
| Martin Houston | M | 66 |
Newcastle University
| 4 years |
| Ole H. Slorer | M | - |
Newcastle University
| 4 years |
| Gary Patou | M | 65 | 4 years | |
| Alan Armstrong | M | - |
Newcastle University
| 3 years |
| Sharon Rowlands | F | 65 |
Newcastle University
| 4 years |
| Alan Hastings Drummond | M | - | 12 years | |
| Eliseo Salinas | M | 69 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 1 years |
| João Paulo Simoes Carrêlo | M | 65 |
Newcastle University
| 4 years |
| Andrew Bird | M | 60 |
Newcastle University
| 4 years |
| Paul Glover | M | - |
Newcastle University
| 1 years |
| Jean-Sébastien Cleiftie | M | 50 |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | 5 years |
| Siew Cheong Ho | M | 61 |
Newcastle University
| 4 years |
| Chun Ning Liu | M | 62 |
Newcastle University
| 4 years |
| Silvia Cheung | F | - |
Newcastle University
| 4 years |
| Seen Tu Sang | M | 55 |
Newcastle University
| 4 years |
| Wing Nang Chan | M | 63 |
Newcastle University
| 4 years |
| Chang Choong Chong | M | 67 |
Newcastle University
| 4 years |
| Gerard Anthony Manley | M | 66 |
Newcastle University
| 4 years |
| Nam Kong Bong | M | 67 |
Newcastle University
| 4 years |
| Keith Norman | M | - |
Newcastle University
| 3 years |
| David Twist | M | 70 |
Newcastle University
| 3 years |
| Ian M. Oades | M | 56 |
Newcastle University
| 4 years |
| Ahmad Ruslan Zahari bin Zakaria | M | 63 |
Newcastle University
| 4 years |
| Tony Gray | M | - |
Newcastle University
| 4 years |
| Cheng Wah Chang | M | 67 |
Newcastle University
| 4 years |
| Tony Starling | M | - |
Newcastle University
| 4 years |
| Donna McLaren | F | - |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | - |
| Susan E. Barrowcliffe | F | 66 | 13 years | |
| Philip J. Coggins | M | - |
Newcastle University
| 3 years |
| Anwar Ali Mustafa Jumabhoy | M | - |
Newcastle University
| 4 years |
| Wan Azman bin Ismail | M | 61 |
Newcastle University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 67 | 67.00% |
| United States | 17 | 17.00% |
| Canada | 13 | 13.00% |
| France | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stewart Craig
- Personal Network
